Quality of life

Graves' Orbitopathy: A Multidisciplinary Approach - Questions and Answers

Volumn , Issue , 2010, Pages 211-220

  Wiersinga, Wilmar M ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 80051884360     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1159/000320441     Document Type: Chapter

References (23)

1. Testa MA, Simonson DC: Assessment of quality of life outcomes. N Engl J Med 1996;334:834-840.
2. Prummel MF, Mourits MP, Blank L, Berghout A, Koornneef L, Wiersinga WM: Randomized doubleblind trial of prednisone versus radiotherapty in Graveś ophthalmopathy. Lancet 1993;342:949-954.
3. Wilson IB, Cleary PD: Linking clinical variables with health-related quality of life. JAMA 1995;273: 59-65.
4. Terwee CB, Dekker FW, Prummel MF, Wiersinga WM: Graveś ophthalmopathy through the eyes of the patient: a state of the art on health-related qual-ity of life assessment. Orbit 2001;20:281-290.
5. Gerding MN, Terwee CB, Dekker FW, Koornneef L, Prummel MF, Wiersinga WM: Quality of life in patients with Graveś ophthalmopathy is markedly decreased: measurements by the Medical Outcomes Study Instrument. Thyroid 1997;7:885-889.
6. Kahaly GJ, Hardt J, Petrak F, Egle UT: Psychosocial factors in subjects with Graveś ophthalmopathy. Thyroid 2002;12:237-239.
7. Elberling TV, Rasmussen AK, Fedt-Rasmussen U, Hording M, Perrild H, Waldemar G: Impaired health-related quality of life: a prospective study. Eur J Endocrinol 2004;151:549-555.
8. Kahaly GJ, Petrak T, Hardt J, Pitz S, Egle UT: Psychosocial morbidity of Graveś orbitopathy. Clin Endocrinol 2005;63:395-402.
9. Farid M, Roch-Leveq A-C, Levi L, Brody BL, Granet DB, Kikkawa DO: Psychological disturbances in Graveś ophthalmopathy. Arch Ophthalmol 2005; 123:491-496.
10. Terwee CB, Gerding MN, Dekker FW, Prummel MF, Wiersinga WM: Development of disease-specific quality of life questionnaire for patients with Graveś ophthalmopathy: the GO-QoL. Br J Ophthalmol 1998;82:773-779.
11. Terwee CB, Gerding MN, Dekker FW, Prummel MF, van der Pol JP, Wiersinga WM: Test-retest reliability of the GO-QoL: a disease-specific quality of life questionnaire for patients with Graveś ophthalmopathy. J Clin Epidemol 1999;52:875-884.
12. Terwee CB, Wakelkamp I, Tas S, Dekker F, Prummel MF, Wiersinga WM: Long-term effects of Graveś ophthalmopathy on health-related quality of life. Eur J Endocrinol 2002;146:751-757.
13. Park JJ, Sullivan TJ, Mortimer RH, Wagenaar M, Perry-Keene DA: Assessing quality of life in Australian patients with Graveś ophthalmopathy. Br J Ophthalmol 2004;88:75-78.
14. Terwee CB, Dekker FW, Wiersinga WM, Prummer MF, Bossuyt PM: On assessing responsiveness of health-related quality of life instruments: guidelines for instrument evaluation. Qual Life Res 2003;12: 349-362.
15. European, American, Latin-American, Japanese and Asia-Oceania Thyroid Associations: Classification of eye changes of Graveś disease. Thyroid 1992;2:235-236.
16. The European Group on Graveś Orbitopathy (EUGOGO): Clinical assessment of patients with Graveś orbitopathy: the European Group on Graveś Orbitopathy recommendations to generalists, specialists and clinical researchers. Eur J Endocrinol 2006;155:387-389.
17. Terwee CB, Dekker FW, Mourits MP, Gerding MN, Baldeschi L, Kalmann R, Prummel MF, Wiersinga WM: Interpretation and validity of changes in scores on the Graveś ophthalmopathy quality of life questionnaire (GO-QoL) after different treatments. Clin Endocrinol 2001;54:391-398.
18. Bartley GB, Fatourechi V, Kadrmas EF, Jacobson SJ, Hstrup DM, Garrrity JA, Gorman CA: Long-term follow-up of Graveś ophthalmopathy in an incidence cohort. Opthalmology 1996;103:958-962.
19. Sprangers MAG, de Regt EB, Andries F, van Agt HME, Bijl RV, Boer JB, Foets M, Hoeymans N, Jacobs AE, Kempen GJJM, Miedema HS, Tijhuis MAR, de Haes HCJM: Which chronic conditions are associated with better or poorer quality of life? J Clin Epidemiol 2000;53:895-907.
20. Fayers P, Bjordal K: Should quality-of-life needs influence resource allocation? Lancet 2001;357: 978.
21. Detmar SB, Muller MJ, Schornagel JH, Wever LDV, Aaronson NK: Health-related quality-of-life assessments and patient-physician communication. A randomized controlled trial. JAMA 2002;288:3027-3034.
22. Velikova G, Booth L, Smith AB, Brown PM, Lynch P, Brown JM, Selby PJ: Measuring quality of life in routine oncology practice improves communication and patient well-being: a randomized contolled trial. J Clin Oncol 2004;22:714-724.
23. Coulter I, Frewin S, Krassas G, Perros P: Psychological implications of Graveś orbitopathy. Eur J Endocrinol 2007;157:127-131.